etoposide and carboplatin
Phase 2Small molecule
etoposide and carboplatin is one of 14 small molecule programs targeting Carboplatin. It is currently in Phase 2.
1
Indications
1
Total Trials
1
Active Trials
13
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
15 competitors in Carboplatin
#DrugCompanyPhaseTrials
1Paraplatin
AAvyxa
Approved
Taxol
TevaPhase 3
Avastin
RochePhase 3
Perjeta
RochePhase 2
Zytiga
Johnson & JohnsonPhase 2
Jevtana
SanofiPhase 2
Herceptin
OOrganon and Co
Phase 2
Rayos
RRoxane Laboratories
Phase 2
MEDI4736
AstraZenecaPhase 2
Serplulimab
Shanghai Henlius BiotechPhase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for etoposide and carboplatin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- HHunan Province Tumor Hospital